Shanghai HeartCare Medical Technology Corporation Limited (HKG:6609)

Hong Kong · Delayed Price · Currency is HKD

47.60

-0.30 (-0.63%)

Jul 31, 2026, 4:08 PM HKT

HKG:6609 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	408.29	408.29	277.9	232.34	183.03	90.09
Revenue Growth	21.90%	46.92%	19.61%	26.94%	103.17%	518.66%
Gross Profit	272.17	272.17	173.66	151.79	123.88	54.95
Operating Income	44.27	44.27	-33.34	-126.87	-199.62	-159.58
Net Income	83.34	83.34	-13.62	-94.01	-200.38	-194.23
Earnings Per Share	2.20	2.20	-0.36	-2.47	-5.24	-5.82
EPS Growth	97.23%	-	-	-	-	-

Revenue by Geography

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Mainland China	391.38	391.38	269.5	231.27	182.91	90.06
Others	16.9	16.9	8.4	1.07	0.12	0.03
Total	408.29	408.29	277.9	232.34	183.03	90.09

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	786.48	786.48	713.72	721.14	870.12	1,218
Total Debt	42.72	42.72	35.75	36.38	50.69	41.94
Net Cash (Debt)	743.76	743.76	677.97	684.76	819.44	1,176
Net Cash Growth	10.63%	9.70%	-0.99%	-16.44%	-30.31%	93.47%
Net Cash Per Share	19.60	19.60	17.95	17.98	21.41	35.21

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	154.14	154.14	-3.23	-88.41	-266.77	-205.85
Capital Expenditures	-11.59	-11.59	-4.04	-4.58	-36.51	-52.83
Free Cash Flow	142.55	142.55	-7.27	-92.98	-303.28	-258.69
Free Cash Flow Growth	366.49%	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	66.66%	66.66%	62.49%	65.33%	67.68%	60.99%
Operating Margin	10.84%	10.84%	-12.00%	-54.60%	-109.06%	-177.13%
Pretax Margin	21.16%	21.16%	-4.32%	-44.30%	-109.95%	-219.68%
Profit Margin	20.41%	20.41%	-4.90%	-40.46%	-109.48%	-215.59%
FCF Margin	34.91%	34.91%	-2.62%	-40.02%	-165.70%	-287.14%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 1, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	19.44	22.12	-	-	-	-
Forward PE	-	33.00	29.68	-	-	-
P/FCF Ratio	11.36	12.93	-	-	-	-
PS Ratio	3.97	4.51	2.83	4.43	6.85	36.80